Human immunodeficiency virus 1 (GP41 Protein) antibody and antigen (Recombinant protein)
Diagnostic antibodies (anti-Human immunodeficiency virus 1, anti-GP41 Protein) and antigens (recombinant protein) for Infectious disease GP41 Protein detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-IVD-P003-Tg001-Ag01 | Recombinant human Human immunodeficiency virus 1 (HIV-1) GP41 Protein Protein | 3090 |
GMP-IVD-P003-Tg001-Ab01 | Anti-human Human immunodeficiency virus 1 (HIV-1) GP41 Protein mouse monoclonal antibody (mAb) | 1953 |
GMP-IVD-P003-Tg001-Ab02 | Anti-human Human immunodeficiency virus 1 (HIV-1) GP41 Protein mouse monoclonal antibody (mAb) | 1953 |
GMP-IVD-P003-Tg001-Ab03 | Anti-human Human immunodeficiency virus 1 (HIV-1) GP41 Protein human monoclonal antibody (mAb) | 1953 |
GMP-IVD-P003-Tg001-Ab04 | Anti-human Human immunodeficiency virus 1 (HIV-1) GP41 Protein human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-IVD-P003-Tg001-Ag01 |
Product Name | Recombinant human Human immunodeficiency virus 1 (HIV-1) GP41 Protein Protein |
Pathogen | Human immunodeficiency virus 1 |
Target/Biomarker | GP41 Protein |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | GP41 Protein (GP41 Protein) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in GP41 Protein level test of Infectious disease (Acquired immunodeficiency syndrome (AIDS)) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant human Human immunodeficiency virus 1 (HIV-1) GP41 Protein Protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-IVD-P003-Tg001-Ab01, GMP-IVD-P003-Tg001-Ab02 |
Product Name | Anti-human Human immunodeficiency virus 1 (HIV-1) GP41 Protein mouse monoclonal antibody (mAb) |
Pathogen | Human immunodeficiency virus 1 |
Target/Biomarker | GP41 Protein |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | GP41 Protein (GP41 Protein) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in GP41 Protein level test of Infectious disease (Acquired immunodeficiency syndrome (AIDS)) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human Human immunodeficiency virus 1 (HIV-1) GP41 Protein mouse monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-IVD-P003-Tg001-Ab03, GMP-IVD-P003-Tg001-Ab04 |
Product Name | Anti-human Human immunodeficiency virus 1 (HIV-1) GP41 Protein human monoclonal antibody (mAb) |
Pathogen | Human immunodeficiency virus 1 |
Target/Biomarker | GP41 Protein |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | GP41 Protein (GP41 Protein) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in GP41 Protein level test of Infectious disease (Acquired immunodeficiency syndrome (AIDS)) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human Human immunodeficiency virus 1 (HIV-1) GP41 Protein human monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Acquired immunodeficiency syndrome (AIDS) is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV). By damaging your immune system, HIV interferes with your body's ability to fight infection and disease. HIV is a sexually transmitted infection (STI). It can also be spread by contact with infected blood or from mother to child during pregnancy, childbirth or breast-feeding. Without medication, it may take years before HIV weakens your immune system to the point that you have AIDS.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments